Systems Biology towards Novel Chronic Kidney Disease Diagnosis and Treatment.
Chronic kidney disease (CKD) caused primarily by diabetes and hypertension has a life-threatening and profound impact on the lives of a large number of patients in Europe. About 50 millionpeople – ten percent of Europe’s general population – are affected by the early stages of CKD. In these stages, the disease typically triggers cardiovascular complications and bone metabolism disorders. When CKD progresses, it makes patients dependent on renal dialysis and, eventually, kidney transplantation.
SysKid integrates a balanced mix of clinicians, statisticians, epidemiologists, molecular researchers and bioinformaticians from universities, small- and medium-sized enterprises as well as industry partners. This interdisciplinary approach aims at understanding the pathophysiology of chronic kidney disease, which in turn will provide tools both for identifying person.
Researchers of the Medical University of Vienna
The Medical University of Vienna is project partner under the leadership of Prof. Rainer Oberbauer / KIM III.
Scientific staff at the Medical University of Vienna:
Alexander Kainz, PhD
Milan Hronsky, PhD
Daniela Dunkler, PhD
Maria Kohl, MS
Project coordinator: Bernd Mayer, emergentec Wien; Georg Heinze, CEMSIIS, Medical University of Vienna.
Project partners: 26
|Topic||HEALTH-2009-2.4.5-2: Cellular and molecular mechanisms of the development of chronic kidney disease (CKD)|
|Project Number||241544, Large-scale integrating project|
|Project duration||1.1.2010 - 31.12.2014|
|Funding volume, total||€ 16 Mio|
|Funding volume, Medical University of Vienna||€ 965380 total, 41% CEMSIIS|